亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台,協助業界發掘知識產權貿易商機,並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權,或是製造商需要購買技術以提高操作效能,又或是知識產權配套服務供應商,你將會從本網站發掘到有用的知識產權貿易資訊。

Methods and Materials to Treat Lymphangiogenesis

技術優勢
Local or systemic administrationDemonstrated in mouse modelDemonstrated in human in vitro culture system
技術應用
Corneal vascularization in various diseasesCorneal transplants in low-risk and high-risk settingsOther tissue or organ transplantOther immune- or lymphatic-related disorders, such as cancer metastasis
詳細技術說明
None
*Abstract
The lymphatic vascular network penetrates most tissues in the body and plays important roles in a broad spectrum of functions, including immune surveillance, fat absorption and interstitial fluid homeostasis. Numerous disorders have been found to be associated with lymphatic dysfunction, such as cancer metastasis, inflammatory and immune diseases, infection, transplant rejection, obesity, hypertension and lymphedema. However, to date, there is still little effective treatment for most lymphatic disorders. Researchers at UC Berkeley (UCB) are working to advance the understanding of the mechanisms underlying pathologic lymphatic processes, such as lymphangiogenesis (LG), for new preventive measures and treatments. MicroRNAs are a class of small noncoding RNAs that negatively regulate gene expression by binding to complimentary sequences of target messenger RNA. UCB researchers are specifically investigating the role of microRNA 184 (miR-184) in corneal LG in vivo and dermal lymphatic endothelial cells (LECs) in vitro. Using preclinical animal models combined with human cell cultures, the researchers have discovered that miR-184 which is naturally expressed in the cornea is critically involved in LG and could potentially be used as an inhibitor of LG. Further research and understanding of these data may produce targets for miR-184 for new approaches to prevent or treat lymphatic disease which occurs both inside and outside the eye.
*Applications
  • Corneal vascularization in various diseases
  • Corneal transplants in low-risk and high-risk settings
  • Other tissue or organ transplant
  • Other immune- or lymphatic-related disorders, such as cancer metastasis
*Principal Investigation

Name: Lu Chen

Department:


Name: Sammy Grimaldo

Department:

其他

Related Materials

"MicroRNA-184 Regulates Corneal Lymphangiogenesis" by Grimaldo S, Yuen D, Theis J, Ng M, Ecoiffier T, Chen L.


Additional Technologies by these Inventors


Tech ID/UC Case

25508/2016-060-0


Related Cases

2016-060-0

國家/地區
美國

欲了解更多信息,請點擊 這裡
移動設備